Melvin I. Marks

Q: What Schools Are Affiliated With Melvin I. Marks

Melvin I. Marks is affiliated with the following schools: McGill University, University of California, Irvine, University of Oklahoma Health Sciences Center, University of Colorado, University of Oklahoma

Melvin I. Marks's AcademicInfluence.com Rankings

Melvin I. Marks

Philosophy

#9018

World Rank

#12510

Historical Rank

Logic

#6023

World Rank

#7500

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Melvin I. Marks's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Melvin I. Marks Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Melvin I. Marks's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. (1997) (271)
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. (1992) (223)
Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases. (1995) (214)
Therapy for children with invasive pneumococcal infections (1997) (174)
Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. (1980) (165)
Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial. (2002) (157)
Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. (1996) (153)
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. (1981) (141)
Oral antibiotic therapy of skeletal infections in children. (1980) (116)
5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. (1972) (114)
Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. (1992) (112)
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. (1982) (110)
Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis (1999) (108)
Use of Ribavirin in the Treatment of Respiratory Syncytial Virus Infection (1993) (108)
Universal hepatitis B immunization (1992) (106)
Interaction of ketoconazole with rifampin and isoniazid. (1984) (105)
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? (1980) (98)
Torulopsis glabrata--an opportunistic pathogen in man. (1970) (81)
Campylobacter gastroenteritis in children. (1979) (79)
Efficacy of Cold Enrichment Techniques for Recovery of Yersinia enterocolitica from Human Stools (1979) (75)
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. (1971) (73)
Screening for Tuberculosis in Infants and Children (1994) (69)
Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. (1985) (69)
The histochemical nitroblue tetrazolium reduction test in the differential diagnosis of acute infections. (1971) (68)
American Academy of Pediatrics Committee on Infectious Diseases: The use of oral acyclovir in otherwise healthy children with varicella. (1993) (67)
Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Committee on Infectious Diseases. (1996) (64)
Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic (1987) (63)
Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases. (1997) (63)
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. (1981) (62)
Synergistic action of amphotericin B and rifampin against Rhizopus species (1987) (60)
Penicillin-insensitive pneumococci. Case report and review. (1979) (59)
Chemotherapy for Tuberculosis in Infants and Children (1992) (57)
A controlled trial comparing sulfametboxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children. (1973) (55)
Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus (1978) (54)
Update on Tuberculosis Skin Testing of Children (1996) (53)
Carbenicillin: a clinical and laboratory evaluation. (1970) (53)
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. (1986) (52)
Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. (1984) (51)
Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus Infection (1993) (51)
The glomerulopathy of congenital syphilis--an immune deposit disease. (1972) (50)
Vitamin A levels in children with measles in Long Beach, California. (1992) (49)
Passive immunization in experimental Herpesvirus hominis infection of newborn mice (1975) (48)
Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. (1972) (46)
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis (1982) (46)
Meningococcal colonization and infection in children and their household contacts. (1979) (44)
Proteinuria in Children with Febrile Illnesses (1970) (43)
Erythromycin in treatment of Campylobacter enteritis in children. (1983) (43)
Infections in bone marrow transplant recipients. (1986) (42)
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin (1981) (42)
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound (1983) (41)
Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. (1993) (41)
Pneumococcal meningitis in children. (1977) (41)
Activity of Newer Aminoglycosides and Carbenicillin, Alone and in Combination, Against Gentamicin-Resistant Pseudomonas aeruginosa (1976) (40)
In Vitro Susceptibility of Haemophilus influenzae to Sulfamethoxazole-Trimethoprim and Cefaclor, Cephalexin, and Cephradine (1978) (39)
Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases. (1996) (38)
Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis (1986) (38)
Vitamin A treatment of measles (1993) (37)
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum (1985) (34)
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. (1987) (34)
Is Clostridium difficile pathogenic in infants? (1982) (34)
Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA. (1985) (33)
Single-dose pharmacokinetics of aztreonam in pediatric patients (1984) (33)
Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis. (1992) (33)
In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid (1985) (32)
Acellular pertussis vaccine: recommendations for use as the initial series in infants and children. American Academy of Pediatrics Committee on Infectious Diseases. (1997) (32)
Update on timing of hepatitis B vaccination for premature infants and for children with lapsed immunization. American Academy of Pediatrics Committee on Infectious Diseases. (1994) (31)
In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). (1971) (31)
Ribavirin: adverse drug reactions, 1986 to 1988 (1990) (30)
Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis. (1987) (30)
American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update. (1991) (30)
Antimicrobial Susceptibilities of Yersinia enterocolitica Biotype 4, Serotype O:3 (1977) (30)
Clinical manifestations of coxsackievirus infections in children. (1974) (29)
Pediatric nocardiosis. (1982) (29)
Successful treatment of Candida meningitis with amphotericin B and 5-fluorocytosine in combination. (1976) (29)
Clinical significance of Staphylococcus aureus in cystic fibrosis (2005) (29)
The timing of tuberculin tests in relation to immunization with live viral vaccines. (1975) (29)
Clinical spectrum and carrier state of nontyphoidal salmonella infections in infants and children. (1974) (28)
Chloramphenicol: properties and clinical use. (1982) (27)
In vitro activity of BMY-28100 against common isolates from pediatric infections (1987) (26)
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients (1984) (26)
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution (1980) (26)
Influences of Media and Inocula on the In Vitro Susceptibility of Haemophilus influenzae to Co-Trimoxazole, Ampicillin, Penicillin, and Chloramphenicol (1975) (26)
Bacterial Meningitis in Children: Diagnosis and Therapy (1987) (25)
Candida Albicans Infections in Hospitalized Children (1975) (24)
Prevalence of Chlamydial antibodies in children. (1982) (24)
The relationship between pertussis vaccine and central nervous system sequelae: continuing assessment. American Academy of Pediatrics Committee on Infectious Diseases. (1996) (24)
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates. (1985) (23)
Development of Haemophilus influenzae meningitis in patients treated with cefamandole. (1981) (22)
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin (1982) (22)
Yeast colonization in hospitalized and nonhospitalized children. (1975) (21)
Moxalactam therapy of Haemophilus influenzae type b meningitis in children. (1984) (21)
Chloramphenicol in the 1980s (1984) (20)
Treatment of streptococcal pharyngitis. I. Clinical evaluation. (1973) (20)
Ceftriaxone therapy in pediatric patients. (1983) (20)
Yersinia enterocolitica: Comparative In Vitro Activities of Seven New β-Lactam Antibiotics (1982) (19)
VARIABLES INFLUENCING THE IN VITRO SUSCEPTIBILITIES OF HERPES SIMPLEX VIRUSES TO ANTIVIRAL DRUGS (1974) (19)
Progressive cough associated with lymphocytic leukemoid reaction in an infant. (1980) (18)
Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis (1982) (18)
Hemophilus influenzae b meningitis in identical twins of a triplet sibship. (1974) (18)
Erysipelaslike lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis. (1982) (17)
Benign familial hematuria. (1969) (17)
American Academy of Pediatrics Committee on Infectious Disease: Acellular pertussis vaccines: recommendations for use as the fourth and fifth doses. (1992) (17)
Pasteurella ureae meningoencephalitis. (1978) (16)
Excellent outcome of Bacteroides meningitis in a newborn treated with metronidazole. (1980) (16)
In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid. (1991) (16)
Recommended timing of routine measles immunization for children who have recently received immune globulin preparations. American Academy of Pediatrics Committee on Infectious Diseases. (1994) (16)
Cefaclor therapy twice daily for acute otitis media. Controlled comparative study of twice-daily vs thrice-daily dose schedule. (1982) (16)
Serial 67Ga-Citrate Imaging During Treatment of Acute Osteomyelitis in Childhood (1978) (16)
Parainfluenza virus immunofluorescence. In vitro and clinical application of the direct method. (1971) (15)
Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics (1983) (15)
In Vitro Antibacterial Activity of Amikacin, a New Aminoglycoside, Against Clinical Bacterial Isolates from Children (1975) (15)
Diagnosis of bacterial infections of the newborn infant. (1981) (15)
American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines. (1993) (15)
American Academy of Pediatrics Committee on Infectious Diseases: The relationship between pertussis vaccine and brain damage: reassessment. (1991) (15)
Carbenicillin in therapy of systemic infections due to Pseudomonas. (1970) (15)
Gianotti disease or Gianotti-Crosti syndrome? (1982) (14)
Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach. (1989) (14)
Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. (1996) (14)
Aztreonam therapy for serious gram-negative infections in children. (1986) (14)
Prevalence of Chlamydia trachomatis antibodies in cord blood. (1981) (14)
An outbreak of severe pneumonia due to respiratory syncytial virus in isolated Arctic populations. (1975) (14)
In Vitro Sensitivity of Salmonella to Ten Antimicrobial Agents Including Sulfamethoxazole and Trimethoprim, Alone and in Combination (1973) (14)
Susceptibilities of bacteria to different antibiotic regimens. Study in two nursery populations. (1975) (13)
Pasteurella multocida Arthritis and Osteomyelitis (1969) (13)
Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis. (1973) (13)
Respiratory viruses in cystic fibrosis. (1984) (13)
Fatal Herpesvirus hominis encephalitis in a white-handed gibbon. (1982) (13)
Nephropathy and persistent proteinuria after albumin administration in the rat. (1970) (12)
Meningococcal meningitis in children. (1979) (12)
Cystic Fibrosis Pulmonary Infections: Lessons from Around the World (1996) (12)
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum (1990) (12)
Leiomyoma presenting as prolonged fever, anemia, and thrombocytosis (1983) (11)
Lower Respiratory Infections (1985) (11)
Influenza Vaccination in Asthmatic Children on Maintenance Theophylline Therapy (1982) (11)
Cefoperazone pharmacokinetics in acute childhood meningitis. (1983) (11)
Pulmonary infections in patients with cystic fibrosis: where to now? (1986) (11)
In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae. (1975) (11)
Hydrocarbon pneumonitis. (1974) (11)
Exchange transfusion in the treatment of hepatic coma. (1969) (11)
Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model. (1975) (11)
Soft-tissue infections caused by Mycobacterium fortuitum complex following penetrating injury. (1987) (10)
Model of neonatal meningitis caused by Escherichia coli K1 in guinea pigs. (1980) (10)
Direct immunofluorescent studies of infection with respiratory syncytial virus. (1970) (10)
Evaluation of three antibiotic programs in newborn infants. (1978) (10)
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. (1970) (10)
Clinico-Pharmacological Studies of Sisomicin in Ill Children (1978) (10)
Intradermal influenza immunization. Experience with Hong Kong vaccine. (1971) (9)
Neurotoxicity of penicillin. (1968) (9)
Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients. (1986) (9)
In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum (1990) (9)
Secondary rates of Haemophilus influenzae type b disease among day care contacts. (1987) (9)
Immunotherapy and drugs in neonatal disseminated herpes simplex virus type 2 infections: a mouse model. (1979) (8)
Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis (1990) (8)
In vitro activity of ciprofloxacin against pediatric pathogens. (1985) (8)
Ringworm resulting from swimming with a polyurethane cast. (1983) (8)
Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological media. (1970) (8)
A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis. (1985) (8)
Therapy for bacterial meningitis: which drugs, and for how long? (1987) (8)
Rapid identification of herpes simplex virus in tissue culture by direct immunofluorescence. (1971) (7)
Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia. (1985) (7)
Antibiotic therapy of serious Haemophilus infections--a continuing problem. (1981) (7)
Experimental animal model for encephalitis due to herpes simplex virus. (1973) (7)
Pulmonary infections in children with cystic fibrosis. (1987) (7)
Pertussis Complicated by the Syndrome of Inappropriate Antidiuretic Hormone Secretion (1986) (7)
Pediatric Infectious Diseases for the Practitioner (1984) (7)
Summary of focused group discussions (1990) (7)
Invasive Haemophilus influenzae type B infections: a continuing challenge. (1990) (6)
New agents in diarrhea (1982) (6)
Ceftriaxone--and more to come. (1983) (6)
Infection due to Yersinia enterocolitica in children with abdominal pain. (1982) (6)
Hyperproteinemic Proteinuria Induced by Plasma Infusion (1969) (6)
American Academy of Pediatrics Committee on Infectious Diseases: The status of acellular pertussis vaccines: current perspective. (1991) (6)
Reevaluation of the Disk Diffusion Method for Sulfonamide Susceptibility Testing of Neisseria meningitidis (1976) (6)
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools (1979) (6)
Evaluation of Amoxicillin Therapy in Ill Children (1978) (6)
Adverse reactions to 1975 bivalent influenza vaccine in children. (1977) (6)
Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli. (1975) (5)
Haemophilus influenzae b bacteremia and meningitis in infant rabbits after intranasal inoculation. (1983) (5)
Lethal Haemophilus influenzae type b infection in mice (1982) (5)
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin. (1982) (5)
"Acne vaccinatum"--a complication of smallpox vaccination. (1971) (5)
Respiratory Syncytial Virus Infection: The Expanded Clinical Spectrum (1993) (5)
Clinical manifestations of Coxsackie virus infections in children. (1974) (5)
Gianotti disease in a child and acute hepatitis B in mother. (1981) (5)
Clinical use of ribavirin in the future (1990) (5)
Fatal hepatitis in siblings: isolation of coxsackievirus B5 and herpes simplex virus. (1970) (4)
Common bacterial infections in infancy and childhood. 4. Skin and wound infections. (1978) (4)
The Long‐Term Prognosis of Aseptic Meningitis in Childhood (1970) (4)
Hemophilus influenzae type b meningitis in infant rabbits. Pathogenesis and therapy. (1984) (4)
In vitro activity of netilmicin (SCH 20569) against bacterial isolates from ill children. (1978) (4)
Synergistic antiviral effects of acyclovir and vidarabine on herpes simplex infection in newborn mice. (1985) (3)
Comparative analysis of Haemophilus influenzae type b and Escherichia coli J5 lipopolysaccharides. (1986) (3)
794 YERSINIA ENTEROCOLITICA GASTROENTERITIS IN CHILDREN (1978) (3)
Recurrent herpes simplex. (1982) (3)
Pharmacokinetics and efficacy of trimethoprim-sulfamethoxazole in the treatment of gastroenteritis in children. (1975) (3)
Effect of Inoculum Size on Type b Susceptibility to New and Conventional Antibiotics. (1983) (3)
Oral therapy for orthopedic infections in children and adults. (1984) (3)
Laboratory and clinical features of influenza A2 1971-72 in Montreal. (1974) (3)
Bacterial Meningitis—An Update (1991) (3)
Ampicillin-resistant strains of Hemophilus influenzae. (1975) (3)
The cephalosporins. Are they as important as their numbers suggest? (1978) (3)
Administration of the third dose of oral poliomyelitis vaccine at 6 to 18 months of age. American Academy of Pediatrics Committee on Infectious Diseases. (1994) (3)
Chloramphenicol: recent developments and clinical indications. (1982) (3)
EVALUATION OF VERTIGO FOLLOWING HEAD INJURIES (1941) (3)
Wolman's disease. (1968) (2)
Recent advances in the treatment of meningitis, including steroids (1991) (2)
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis. (1985) (2)
Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activity. (1973) (2)
Recommended Childhood Immunization Schedule (1996) (2)
Respiratory Syncytial Virus Infections (1992) (2)
Treatment of cystic fibrosis with trimethoprim-sulfamethoxazole. (1984) (2)
Adverse drug reactions : United States experience. II (1990) (2)
Haemophilus influenzae Infections (1984) (2)
In vitro studies of antibacterial activity (2007) (2)
The Exposure of Health Care Workers to Ribavirin Aerosol (1989) (2)
Current concepts of smallpox and rubella immunization. (1972) (1)
Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children. (1974) (1)
Common bacterial infections in infancy and childhood. 1. Respiratory infections. (1978) (1)
Serum standards for the bioassay of aminoglycosides in cerebrospinal fluid. (1978) (1)
Herpangina and pleurodynia associated with Herpes simplex virus. (1971) (1)
Immunogenicity and adverse reactions of A/Swine, A/Victoria whole-virus influenza vaccine in high-risk children. (1979) (1)
Infectious diarrhea: introduction and commentary. (1994) (1)
Respiratory infections vs colonization (1982) (1)
Aseptic meningitis due to echovirus type 9. (1972) (1)
Epidemiology of disease in isolated populations. (1971) (1)
Method for the preparation of a herpesvirus hominis fluorescent conjugate for direct immunofluorescence (2005) (1)
Enoxacin pharmacokinetics and efficacy in CF-1 mice. (1987) (1)
RED BOOK RECOMMENDATIONS ON RIBAVIRIN CHALLENGED. AUTHORS' REPLY (1994) (1)
Arthritis associated with Haemophilus influenzae meningitis. (1987) (1)
Iatrogenic pneumaturia. (1971) (1)
Yersinia Enterocolitica Gastroenteritis in Children and Their Families (2018) (1)
THE POTENTIAL FOR ORAL ANTIBIOTIC THERAPY FOR PSEUDOMONAS INFECTIONS IN CHILDREN (1984) (1)
Pediatric antimicrobial therapy 3. (1973) (1)
Prolonged and secondary fevers in childhood bacterial meningitis. (1992) (1)
Pediatric infectious diseases (1993) (1)
Bacterial meningitis in infants and children (1984) (1)
DIAGNOSTIC USEFULNESS OF THE NITROBLUE TETRAZOLIUM DYE REDUCTION TEST IN A CHILDREN'S HOSPITAL (1974) (1)
Common Bacterial Infections in Infancy and Childhood (1978) (1)
Nitroblue tetrazolium dye reduction test. Preliminary in vitro studies of factors involved in dye reduction. (1973) (1)
Coxsackieviruses in human disease. (1975) (1)
Antibiotic Therapy of Fulminant E. coli K1 Sepsis in Infant Rabbits (1984) (1)
Adverse reactions to 1975 bivalent influenza vaccine in children. (1977) (1)
PARAINFLUENZA VIRUS IMMUNOFLUORESCENCE (1971) (1)
Effect of Inoculum Size on Haemophilus influenzae Type b Susceptibility to New and Conventional Antibiotics (1983) (1)
Intradermal Influenza Immunization (2015) (1)
Neonatal infectious disease and immunology (1991) (1)
Common Bacterial Infections in Infancy and Childhood (1979) (1)
Activities of Various ,-Lactams and Aminoglycosides, Alone and in Combination, Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis (2003) (0)
Some current concepts of the treatment of head and neck cancer. (1959) (0)
Pharmacokinetics of tobramycin in neonates. (1984) (0)
Book ReviewFever: From symptom to treatment. (1978) (0)
Endobronchial Tuberculosis Presenting as Respiratory Failure in an Infant (1993) (0)
[Clinical and biological aspects of meningococcal infections in children]. (1973) (0)
Skin and Wound Infections (1979) (0)
Monitoring aminoglycoside therapy. (1987) (0)
[Immunofluorescence in clinical and laboratory studies on Herpes simplex virus]. (1973) (0)
Adverse drug reactions: United States experience. II (1990) (0)
Legend. Isolation of Yersinia enterocolitica, Campylobacterjejuni, Salmonella, and Shigella from the stool and/or appendix of children with abdominal pain. (1982) (0)
Haemophilus influenzae type B and pyogenic osteomyelitis. (1982) (0)
IMIPENEM PHARMACOKINETICS IN CHILDREN (1984) (0)
Urinary Tract Infection in Children (1993) (0)
Single-Dose Pharmacokinetics ofAztreonam inPediatric Patients (1984) (0)
BIOAVAILABILITY AND CSF PENETRATION OF CIPROFLOXACIN IN EXPERMENTAL HAEMOPHILUS INFLUENZAE MENINGITIS (1987) (0)
Treatment of bacterial pneumonia. (1985) (0)
Common bacterial infections in infancy and childhood. 3. Genitourinary infections. (1978) (0)
Common Bacterial Infections in Infancy and Childhood (2012) (0)
Serumstandards forthebioassay ofaminoglycosides incerebrospinal fluid (1978) (0)
Management of cellulitis. (1981) (0)
Exchange transfusion h@atic coma in the treatment of (1969) (0)
Communicable and Infectious Diseases. (1977) (0)
Marks , McLaine , and Drummond TABLE III Clinical and Laboratory Data on Patients with Febrile Proteinuria IUrine Protein Urine Total Serum Case Diagnosis Age Sex Temperature I Concentration (2007) (0)
Pediatric antimicrobial therapy I. (1973) (0)
Bacteriol meningitis in infants and children (1984) (0)
Influences ofMediaandInocula ontheInVitro Susceptibility ofHaemophilus influenzae toCo-Trimoxazole, Ampicillin, Penicillin, andChloramphenicol (1975) (0)
Publish and perish! (1983) (0)
Infections of the Newborn (1985) (0)
Sequential bullous impetigo and cutaneous herpes simplex virus infection (1982) (0)
Prophylaxis for herpes simplex infection. (1984) (0)
Common bacterial infections in infancy and childhood. 6. Enteric infections. (1978) (0)
Letter: Influenza immunization in children. (1976) (0)
Common Bacterial Infections in Infancy and Childhood (2012) (0)
Principles of Antibacterial Therapy in Infants and Children (1979) (0)
Common bacterial infections in infancy and childhood: diagnosis and treatment. (1979) (0)
5-Fluorocytosine: An Oral Antifungal Compound (2020) (0)
Foreword (1990) (0)
In Vitro Sensitivity of Torulopsis glabrata to Amphotericin B, 5-Fluorocytosine, and Clotrimazole (Bay 5097) (1971) (0)
Letter: Acute rheumatic fever. (1975) (0)
Infections in children (1983) (0)
Lower Respiratory Tract Infection (1993) (0)
Pediatric antimicrobial therapy. V. (1973) (0)
Immunization today--a review. (1973) (0)
False-normal radionuclide scans for osteomyelitis. (1981) (0)
Prevalence of Chlamydia antibodies in cord blood trachomatis (1981) (0)
Are bacterial screening programs in the hospital worthwhile? (1982) (0)
Common Bacterial Infections in Infancy and Childhood (2012) (0)
Epiglottitis, Croup, and Laryngitis (1987) (0)
THREE FRIENDS GONE (1985) (0)
Pediatrics Chemoprophylaxis Guidelines for Prevention of Group B Streptococcal ( GBS ) Infection by Services (2006) (0)
Pediatric antimicrobial therapy. II. (1973) (0)
Treatment of infections in patients with cystic fibrosis (2005) (0)
URIs in children. (1979) (0)
Group B streptococcal infection in the newborn. (1979) (0)
Systemic Infections in Normal and Immunocompromised Hosts (1985) (0)
Respiratory syncytial virus infection in isolated populations. (1995) (0)
AUTHORS' CORRECTIONS TO ARTICLE ON MENINGOCCAL EPIDEMIOLOGY IN CHILDREN AND THEIR CONTACTS (1980) (0)
Pediatric antimicrobial therapy IV. (1973) (0)
Chloramphenicol toxicity. (1986) (0)
878 FAILURE TO ISOLATE A TRANSMISSABLE AGENT FROM THE PANCREAS OF A CHILD WITH NEWLY DIAGNOSED DIABETES MELLITUS (1978) (0)
Is cyclacillin really better? (1983) (0)
Single-dose pharmacokinetics of imipenemcilastatin in pediatric patients (1986) (0)
Summary (1990) (0)
New applications of old antimicrobials. (1986) (0)
Smallpox vaccination. (1973) (0)
Pediatric antimicrobial therapy. VI. (1973) (0)
New concepts in viral gastroenteritis (2005) (0)
Upper Respiratory Infections (1985) (0)
EXPERIMENTAL ESCHERICHIA COLI MENINGITIS IN NEWBORN SOS GUINEA PIGS (1977) (0)
Neonatal sepsis and meningitis due to alpha-hemolytic Streptococcus. (1983) (0)
1080 EVALUATION OF MOXALACTAM FOR THE TREATMENT OF MENINGITIS DUE TO S. PNEUMONIAE WITH DIFFERING SUSCEPTIBILITIES TO PENICILLIN (1981) (0)
Questions Chloramphenicol Recommendations (1977) (0)
Laboratory Identification of Torulopsis glabrata: Typical Appearance on Routine Bacteriological Media (1970) (0)
INFECTION: ANTIBIOTIC THERAPY OF SERIOUS HEMOPHILUS INFECTIONS—A CONTINUING PROBLEM (1981) (0)
1038 PEDIATRIC NOCARDIOSIS (1981) (0)
786 ORAL THERAPY OF BONE & JOINT INFECTIONS: A CONTROLLED PROSPECTIVE STUDY (1978) (0)
AN OUTBREAK OF SEVERE PNEUMONIA DUE TO RESPIRATORY SYNCYTIA VIRUS IN ISOLATED ARCTIC POPULATIONS (1974) (0)
Penicillin prophylaxis in sickle cell disease. (1984) (0)
Respiratory syncytial virus infections. An update (1993) (0)
1160 AN IN VITRO MODEL FOR ASSESSING ANTIMICROBIAL ACTIVITY DURING PERITONEAL DIALYSIS (1985) (0)
VISUALIZATION OF THE EPIGLOTTIS IN PATIENTS WITH CROUP (1985) (0)
Unsubstantiated Comments In Letter. (1971) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Melvin I. Marks?

Melvin I. Marks is affiliated with the following schools: